Independent Pharmacy Cooperative

Largest group purchasing organization for independent pharmacies.

Based in WI

Share:𝕏LinkedInFacebook
🤖

AI Overview

With $1.2M in lobbying spend across 23 quarterly filings, Independent Pharmacy Cooperative is a significant lobbying presence. They deploy 11 individual lobbyists Their lobbying covers 4 issue areas. Active from 2018 to 2025.

$1.2M
Total Spend
7
Years Active
1
Firms Hired
11
Lobbyists Deployed
4
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$180K
2019$240K
2020$120K
2021$180K
2022$240K
2024$100K
2025$120K

Issues Lobbied

Health IssuesPharmacyMedicare/MedicaidBudget/Appropriations

Lobbying Firms

Forbes-tate

Lobbyists

Jerry DriscollJeffrey ForbesJeffrey StrunkElizabeth GreerDerrick WhiteJeffrey SadoskyFranklyn SteinbergCynthia BrownKristina DunklinMichael WilliamsPaul Dioguardi

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Pharmacy, Medicare/Medicaid, Budget/Appropriations

Issues related to Pharmacy Regulation; Issues related to the MAC Transparency Act; Issues related to opioid addiction; Issues related to drug pricing.

Issues related to Pharmacy Regulation; Issues related to the MAC Transparency Act; Issues related to opioid addiction;Issues related to drug pricing.Issues related to Pharmacy Benefit Manager transparency.

Issues related to Pharmacy Regulation; Issues related to the MAC Transparency Act; Issues related to opioid addiction; Issues related to drug pricing; Issues related to Pharmacy Benefit Manager transparency.

Issues related to pharmacy regulation, the MAC Transparency Act, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency.

Issues related to direct and indirect remuneration (DIR) fees.

Issues related to H.R. 925 - The Heroes Act.

Issues related to pharmacy regulation, the MAC Transparency Act, Provider Status, opioid addiction, drug pricing, and Pharmacy Benefit Manager transparency.

Issues related to direct and indirect remuneration (DIR) fees; Issues related to provider status and Medicare reimbursement.

Showing 8 of 15 unique descriptions from filings.

Related Analysis

📈 Client Trajectories
See how this client compares to others over time
🎯 Market Concentration
How concentrated is the lobbying market?
🚀 Spending Momentum
Which issues are surging right now?
🏭 Pharma Lobbying
Industry overview and top spenders

Related Investigations

Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
The 22,000% ROI
When lobbying spending yields outsized returns.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.

Explore More

← All Clients⚖️ Compare Clients💵 ROI Calculator🔍 Investigations📖 How Lobbying Works🕸️ Network Analysis

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.